| Euronext Paris: BIO
BioAlliance Pharma SA develops and manufactures drugs for the treatment of cancer and its associated pathologies. Its product offerings comprise of Orphan Oncology and Specialty. The Orphan Oncology products include drugs for treatment of primary liver cancer, oral mucositis, metastatic melanoma, and rare digestive cancer. The Specialty products include vaccine for H1N1 and drugs for treatment of oropharyngeal candidiasis, oral herpes, and cancer chronic pain. The company was founded on March 5, 1997 by Gilles Avenard and Dominique Costantini and is headquartered in Paris, France.